Menu

Understanding COVID’s Long Game

Floyd Chilton and Thomas Bumol shine light on the pathways that SARS-CoV-2 hijacks to cause disease.

The Creative Services Team in collaboration with Cayman Chemical
Oct 21, 2021

LIVE Webinar

Wednesday, November 17, 2021
3:00 - 4:30 PM Eastern Time

Register Now

In a growing number of people who contract COVID-19, symptoms persist long after the initial SARS-CoV-2 infection subsides. COVID-19 and long COVID patients display a variety of symptoms that reveal SARS-CoV-2’s versatility and its long-lasting impact on organ function. While this heterogeneity makes it difficult to study the disease, scientists apply every available technology to investigate the virus’ pathological mechanisms. In this webinar brought to you by Cayman Chemical, Floyd Chilton and Thomas Bumol will discuss how they combine metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2’s ability to attack multiple organs, even after the virus has been cleared from the body.

Topics to be covered

  • Molecular networks and enzymes that determine COVID-19 mortality
  • Persistent inflammatory signatures in long COVID

Register Now

Meet the Speakers:

Floyd (Ski) H. Chilton, PhD
Professor, School of Nutritional Sciences and Wellness
Director, Precision Nutrition and Wellness Initiative
The University of Arizona


Thomas F. Bumol, PhD
Executive Vice President and Director
Allen Institute for Immunology


December 2021

Return of the worms

Researchers are carefully considering the therapeutic potential of helminths

Marketplace

Sponsored Product Updates

Using 3-D Cell Culture Systems for Extracellular Vesicle Research
3-D cell culture recapitulates in vivo environments for generating physiologically relevant extracellular vesicles.
On the Path to Personalized Medicine
Scientists combine medical care with biobanking and research to develop personalized treatments for cancer patients.
An Early Start: The Impact of the Microbiome on Pediatric Development in the First Year of Life
A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately.
Dr. Aletta Schnitzler Joins TurtleTree as Chief Scientific Officer
Cell-based nutrition company TurtleTree welcomes Dr. Aletta Schnitzler as its new Chief Scientific Officer (CSO). With her world-class expertise in cellular bioprocessing, Dr. Schnitzler’s appointment marks a significant stride in TurtleTree’s journey towards sustainable and efficient cellular food production.